These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34995036)

  • 1. Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratification and Novel Therapies.
    Bishop JR; Zhang L; Lizano P
    Harv Rev Psychiatry; 2022 Jan-Feb 01; 30(1):59-70. PubMed ID: 34995036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.
    Reilly JL; Sweeney JA
    Schizophr Bull; 2014 May; 40(3):516-22. PubMed ID: 24574307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin, myelin-related disorders, and psychosis.
    Mighdoll MI; Tao R; Kleinman JE; Hyde TM
    Schizophr Res; 2015 Jan; 161(1):85-93. PubMed ID: 25449713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetics and epigenetics of schizophrenia and other psychoses].
    Chaumette B; Kebir O; Krebs MO
    Biol Aujourdhui; 2017; 211(1):69-82. PubMed ID: 28682228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).
    Ivleva EI; Bidesi AS; Keshavan MS; Pearlson GD; Meda SA; Dodig D; Moates AF; Lu H; Francis AN; Tandon N; Schretlen DJ; Sweeney JA; Clementz BA; Tamminga CA
    Am J Psychiatry; 2013 Nov; 170(11):1285-96. PubMed ID: 24185241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiopathogenesis and treatment of psychosis.
    Crow TJ; Harrington CA
    Annu Rev Med; 1994; 45():219-34. PubMed ID: 7911014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel gene-brain structure relationships in psychotic disorder revealed using parallel independent component analyses.
    Tandon N; Nanda P; Padmanabhan JL; Mathew IT; Eack SM; Narayanan B; Meda SA; Bergen SE; Ruaño G; Windemuth A; Kocherla M; Petryshen TL; Clementz B; Sweeney J; Tamminga C; Pearlson G; Keshavan MS
    Schizophr Res; 2017 Apr; 182():74-83. PubMed ID: 27789186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis.
    Dazzan P; Soulsby B; Mechelli A; Wood SJ; Velakoulis D; Phillips LJ; Yung AR; Chitnis X; Lin A; Murray RM; McGorry PD; McGuire PK; Pantelis C
    Schizophr Bull; 2012 Sep; 38(5):1083-91. PubMed ID: 21518921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for drug development in early psychosis: Current issues and promising directions.
    Goff DC; Romero K; Paul J; Mercedes Perez-Rodriguez M; Crandall D; Potkin SG
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):923-37. PubMed ID: 27005595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-Life Adversity, Systemic Inflammation and Comorbid Physical and Psychiatric Illnesses of Adult Life.
    Nettis MA; Pariante CM; Mondelli V
    Curr Top Behav Neurosci; 2020; 44():207-225. PubMed ID: 30895531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Brief History of Immunological Research into Psychosis and Pathways for Immune Influence of the Brain.
    Müller N
    Curr Top Behav Neurosci; 2020; 44():1-8. PubMed ID: 30779049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development.
    Egerton A; Grace AA; Stone J; Bossong MG; Sand M; McGuire P
    Schizophr Res; 2020 Sep; 223():59-70. PubMed ID: 33071070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers?
    Bora E; Yucel M; Fornito A; Berk M; Pantelis C
    Acta Psychiatr Scand; 2008 Sep; 118(3):172-87. PubMed ID: 18699952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives.
    Ermakov EA; Melamud MM; Buneva VN; Ivanova SA
    Front Psychiatry; 2022; 13():880568. PubMed ID: 35546942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome and adaptive immunity in schizophrenia.
    Agorastos A; Bozikas VP
    Psychiatriki; 2019; 30(3):189-192. PubMed ID: 31685450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design.
    Nasib LG; Sommer IE; Winter-van Rossum I; de Vries J; Gangadin SS; Oomen PP; Judge G; Blom RE; Luykx JJ; van Beveren NJM; Veen ND; Kroken RA; Johnsen EL
    Trials; 2020 Jun; 21(1):492. PubMed ID: 32513294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia.
    Bartholomeusz CF; Ganella EP; Labuschagne I; Bousman C; Pantelis C
    Schizophr Res; 2015 Nov; 168(3):614-27. PubMed ID: 26123171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls.
    Jacomb I; Stanton C; Vasudevan R; Powell H; O'Donnell M; Lenroot R; Bruggemann J; Balzan R; Galletly C; Liu D; Weickert CS; Weickert TW
    Front Immunol; 2018; 9():2230. PubMed ID: 30364161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.